Work

Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial,

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.3716.3716

Authors: Jeffrey A. Barnes, Kristen Stevenson, Ephraim P. Hochberg, Tak Takvorian, David C. Fisher, Ann LaCasce, Jennifer R. Brown, Anuj K. Mahindra, Donna Neuberg, Jeremy S. Abramson

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550784115

FWCI:

Cites:

Cited by:

Related to: 10